rabeprazole has been researched along with Precordial Catch in 10 studies
Rabeprazole: A 4-(3-methoxypropoxy)-3-methylpyridinyl derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To investigate the efficacy of amitriptyline with proton pump inhibitor (PPI) for the treatment of functional chest pain (FCP)." | 9.17 | Low-dose amitriptyline combined with proton pump inhibitor for functional chest pain. ( Kim, JE; Lee, H; Lee, HJ; Lee, SK; Lee, YC; Park, JC; Park, SW; Shin, SK, 2013) |
| "Therapeutic trials with high-dose lansoprazole and omeprazole have been shown to be sensitive clinical tools for diagnosing patients with gastro-oesophageal reflux disease-related non-cardiac chest pain." | 9.11 | The effect of a therapeutic trial of high-dose rabeprazole on symptom response of patients with non-cardiac chest pain: a randomized, double-blind, placebo-controlled, crossover trial. ( Cui, H; Dickman, R; Emmons, S; Esquivel, RF; Fass, R; Hernández, D; Sewell, J, 2005) |
| "However, during the second week, GERD-related NCCP had a higher positive PPI test (n = 13, 81%) than non GERD-related NCCP (n = 7, 27%) (P = 0." | 6.74 | Comparison of one-week and two-week empirical trial with a high-dose rabeprazole in non-cardiac chest pain patients. ( Kim, JH; Kim, JJ; Rhee, JC; Rhee, PL; Sinn, DH; Son, HJ, 2009) |
| "To investigate the efficacy of amitriptyline with proton pump inhibitor (PPI) for the treatment of functional chest pain (FCP)." | 5.17 | Low-dose amitriptyline combined with proton pump inhibitor for functional chest pain. ( Kim, JE; Lee, H; Lee, HJ; Lee, SK; Lee, YC; Park, JC; Park, SW; Shin, SK, 2013) |
| "Therapeutic trials with high-dose lansoprazole and omeprazole have been shown to be sensitive clinical tools for diagnosing patients with gastro-oesophageal reflux disease-related non-cardiac chest pain." | 5.11 | The effect of a therapeutic trial of high-dose rabeprazole on symptom response of patients with non-cardiac chest pain: a randomized, double-blind, placebo-controlled, crossover trial. ( Cui, H; Dickman, R; Emmons, S; Esquivel, RF; Fass, R; Hernández, D; Sewell, J, 2005) |
| "The research was aimed at evaluating the efficiency of the inhibitor of the Rabeprazole (Pariet) proton pump in the therapy of the gastroesophageal reflux disease (GERD) with extra esophagus manifestations, and the presence of pains in the chest not caused by cardiac diseases." | 5.10 | [Evaluation of the efficacy of pariet in patients with gastroesophageal reflux disease with thoracic pain not connected with cardiac disease]. ( Danilin, MS; Kucheriavyĭ, IuA; Maev, IV, 2003) |
| "Gastroesophageal reflux disease is thought to be the commonest cause of 'non-cardiac chest pain'." | 2.74 | Non-cardiac chest pain: prevalence of reflux disease and response to acid suppression in an Asian population. ( Azman, W; Goh, KL; Mohd, H; Qua, CS; Wong, CH, 2009) |
| "However, during the second week, GERD-related NCCP had a higher positive PPI test (n = 13, 81%) than non GERD-related NCCP (n = 7, 27%) (P = 0." | 2.74 | Comparison of one-week and two-week empirical trial with a high-dose rabeprazole in non-cardiac chest pain patients. ( Kim, JH; Kim, JJ; Rhee, JC; Rhee, PL; Sinn, DH; Son, HJ, 2009) |
| "Unexplained chest pain is potentially attributable to gastro-oesophageal reflux disease (GORD) or oesophageal motility disorders." | 2.47 | Response of unexplained chest pain to proton pump inhibitor treatment in patients with and without objective evidence of gastro-oesophageal reflux disease. ( Howden, CW; Hughes, N; Kahrilas, PJ, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (70.00) | 29.6817 |
| 2010's | 3 (30.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Park, SW | 1 |
| Lee, H | 2 |
| Lee, HJ | 1 |
| Park, JC | 2 |
| Shin, SK | 2 |
| Lee, SK | 2 |
| Lee, YC | 2 |
| Kim, JE | 1 |
| Mohd, H | 1 |
| Qua, CS | 1 |
| Wong, CH | 1 |
| Azman, W | 1 |
| Goh, KL | 1 |
| Kim, JH | 1 |
| Sinn, DH | 1 |
| Son, HJ | 1 |
| Kim, JJ | 1 |
| Rhee, JC | 1 |
| Rhee, PL | 1 |
| Wu, JC | 1 |
| Kahrilas, PJ | 1 |
| Hughes, N | 1 |
| Howden, CW | 1 |
| Maev, IV | 2 |
| Kucheriavyĭ, IuA | 1 |
| Danilin, MS | 1 |
| Dickman, R | 1 |
| Emmons, S | 1 |
| Cui, H | 1 |
| Sewell, J | 1 |
| Hernández, D | 1 |
| Esquivel, RF | 1 |
| Fass, R | 1 |
| Iurenev, GL | 1 |
| Burkov, SG | 1 |
| V'iuchnova, ES | 1 |
1 review available for rabeprazole and Precordial Catch
| Article | Year |
|---|---|
Response of unexplained chest pain to proton pump inhibitor treatment in patients with and without objective evidence of gastro-oesophageal reflux disease.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Chest Pain; Esophagus; Gastroesophageal Reflux; Heartburn; | 2011 |
7 trials available for rabeprazole and Precordial Catch
| Article | Year |
|---|---|
Low-dose amitriptyline combined with proton pump inhibitor for functional chest pain.
Topics: Adrenergic Uptake Inhibitors; Adult; Amitriptyline; Chest Pain; Drug Therapy, Combination; Female; H | 2013 |
Non-cardiac chest pain: prevalence of reflux disease and response to acid suppression in an Asian population.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Asian People; Chest Pain; Endoscopy, Digestive | 2009 |
Comparison of one-week and two-week empirical trial with a high-dose rabeprazole in non-cardiac chest pain patients.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Chest Pain; Drug Administration Schedule; Empi | 2009 |
Segmental changes in smooth muscle contraction as a predictive factor of the response to high-dose proton pump inhibitor treatment in patients with functional chest pain.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Chest Pain; Drug Administration Schedule; Esophageal | 2012 |
[Evaluation of the efficacy of pariet in patients with gastroesophageal reflux disease with thoracic pain not connected with cardiac disease].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Benzimidazoles; Chest Pain; Enzyme Inhibitors; Femal | 2003 |
The effect of a therapeutic trial of high-dose rabeprazole on symptom response of patients with non-cardiac chest pain: a randomized, double-blind, placebo-controlled, crossover trial.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Ulcer Agents; Benzimidazoles; Chest Pain; | 2005 |
[Rabeprazole test and comparison of the effectiveness of course treatment with rabeprazole in patients with gastroesophageal reflux disease and non-coronary chest pain].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Ulcer Agents; Chest Pain; Female; Gastroe | 2007 |
2 other studies available for rabeprazole and Precordial Catch
| Article | Year |
|---|---|
[Proton pump inhibition: more than only reflux therapy].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Asthma; Chest Pain; Clopidogrel; Comorbi | 2008 |
Is longer duration of proton pump inhibitor trial better for gastroesophageal reflux disease-related non-cardiac chest pain?
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Chest Pain; Clinical Trials as Topic; Drug Administration S | 2009 |